INNATE PHARMA by Innate Pharma (IPHYF) Stock Price, Quote, News & History

IPHYFOTCPK
$1.65
At close: Jun 24, 5:00 PM EST
Loading...

Key Statistics

Open
-
Close
-
Volume / Avg.
0 / 2.00K
Day Range
- - -
52 Wk Range
1.31 - 2.25
Market Cap
-
P/E Ratio
-
Dividend Yield
-
Exchange
OTC
RSI
-
Short Interest
-
Days to Cover
1

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-32.56M
Investing Cash Flow (TTM)
20.63M
Financing Cash Flow (TTM)
-1.97M
Free Cash Flow (TTM)
-34.91M
Capital Expenditure (TTM)
-2.35M
Net Change in Cash (TTM)
-13.89M

Valuation Metrics

Enterprise Value
$166.85M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
46.27
PB Ratio (TTM)
-
Earnings Yield % (TTM)
-38.21%
Earnings Yield % (FWD)
-38.90%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
-$0.26

Company Debt

Total Debt
$22.19M
LT Debt
$13.67M
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-$2.36M
Total Cash
$28.09M
Debt to Equity
-
Issuance of Debt (TTM)
-$2.36M
Repayment of Debt (TTM)
-$2.36M

Key Statistics

Open
-
Close
-
Volume / Avg.
0 / 2.00K
Day Range
- - -
52 Wk Range
1.31 - 2.25
Market Cap
-
P/E Ratio
-
Dividend Yield
-
Exchange
OTC
RSI
-
Short Interest
-
Days to Cover
1

About

Sector
Health Care
Industry
Biotechnology
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. The company's approach includes therapeutic modalities such as monoclonal antibodies, multispecific NK cell engagers through ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy INNATE PHARMA by Innate Pharma (IPHYF) stock?

A

You can purchase shares of INNATE PHARMA by Innate Pharma (OTCPK:IPHYF) through any online brokerage.

View our list of the best stock brokerages

Q

Who are INNATE PHARMA by Innate Pharma (IPHYF) competitors?

A

There are no as such competitors for INNATE PHARMA by Innate Pharma.

Q

What is the forecast, or price target, for INNATE PHARMA by Innate Pharma (IPHYF) stock?

A

There is no analysis for INNATE PHARMA by Innate Pharma to provide a consensus price target.

Q

What is the current price for INNATE PHARMA by Innate Pharma (IPHYF)?

A

The stock price for INNATE PHARMA by Innate Pharma (OTCPK: IPHYF) is $1.65 last updated May 27, 2026 at 12:16 PM EDT.

Q

Does INNATE PHARMA by Innate Pharma (IPHYF) pay a dividend?

A

There are no upcoming dividends for INNATE PHARMA by Innate Pharma.

Q

When is INNATE PHARMA by Innate Pharma (OTCPK:IPHYF) reporting earnings?

A

INNATE PHARMA by Innate Pharma does not have any upcoming earnings scheduled.

Q

Is INNATE PHARMA by Innate Pharma (IPHYF) going to split?

A

There is no upcoming split for INNATE PHARMA by Innate Pharma.

Q

What sector and industry does INNATE PHARMA by Innate Pharma (IPHYF) operate in?

A

INNATE PHARMA by Innate Pharma is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.